Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: The 584 Reexam Terminated NIRC

What a PERFECT time for insiders to begin BUYING STOCK!

Just think if they each put just 10% of their annual PTSC earnings toward buying stock between now and the Markman. That would amount to $56K in purchasing. Considering that they have taken in millions in compensation in the last several years without buying an single share, and while steering the pps back to under a nickel, I'd say a combined $56K is well below would should be considered a reasonable amount to invest in the company they are supposed to be getting OTHERS to invest in. It is a mere pittance compared to what other BOD and Executives own in most companies.

At current price levels, that would amount to about 933,000 shares that they could purchase.

Do they believe in their company? Do they believe in their abilities? Do they believe in their PRs that stated the re-exams were the major hurdle, or the litigation with TPL was the major hurdle, etc. etc. etc.?

Here's an opportunity to make a statement to the market! Here's an opportunity to do the right thing! Here's an opportuity to put the past behind them and us!

Will they?

Share
New Message
Please login to post a reply